Items where authors include "Burmester, GR"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 13.

Article

Alunno, A, Najm, A, Machado, PM et al. (21 more authors) (2021) EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases. ISSN 0003-4967

Emery, P orcid.org/0000-0002-7429-8482, Burmester, GR, Naredo, E et al. (4 more authors) (2020) Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the Rheumatic Diseases. ISSN 0003-4967

Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Emery, P orcid.org/0000-0002-7429-8482, Burmester, GR, Bykerk, VP et al. (4 more authors) (2019) Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study. RMD Open, 5 (1). e000840. ISSN 2056-5933

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2019) Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International. ISSN 0172-8172

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2018) On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International, 38 (12). pp. 2225-2231. ISSN 0172-8172

Emery, P, Burmester, GR, Naredo, E et al. (3 more authors) (2018) Design of a Phase 4 Randomized, Double-Blind, Placebo-Controlled Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels, and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Patients (PREDICTRA). BMJ Open, 8 (2). e019007. ISSN 2044-6055

Smolen, JS, Aletaha, D, Barton, A et al. (8 more authors) (2018) Rheumatoid arthritis. Nature Reviews Disease Primers, 4. 18001.

Combe, B, Landewe, R, Daien, CI et al. (20 more authors) (2017) 2016 update of the EULAR recommendations for the management of early arthritis. Annals of the Rheumatic Diseases, 76 (6). pp. 948-959. ISSN 0003-4967

Emery, P, Bingham III, CO, Burmester, GR et al. (11 more authors) (2017) Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Annals of the Rheumatic Diseases, 76 (1). pp. 96-104. ISSN 0003-4967

Emery, P, Bingham III, CO, Burmester, GR et al. (11 more authors) (2016) Response to: ‘Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!’ by Boers. Annals of the Rheumatic Diseases, 75 (10). e69. ISSN 0003-4967

Peterfy, C, Burmester, GR, Bykerk, VP et al. (7 more authors) (2016) Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis. Annals of the Rheumatic Diseases, 75 (8). pp. 1501-1505. ISSN 0003-4967

Smolen, JS, Breedveld, FC, Burmester, GR et al. (40 more authors) (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. British Journal of Sports Medicine, 75 (1). pp. 3-15. ISSN 0306-3674

This list was generated on Sat Mar 23 09:17:48 2024 GMT.